Endothelial cell protection in xenotransplantation: looking after a key player in rejection.
The endothelium, as an organ at the interface between the intra- and extravascular space, actively participates in maintaining an anti-inflammatory and anti-coagulant environment under physiological conditions. Severe humoral as well as cellular rejection responses, which accompany cross-species transplantation of vascularized organs as well as ischemia/reperfusion injury, primarily target the endothelium and disrupt this delicate balance. Activation of pro-inflammatory and pro-coagulant pathways often lead to irreversible injury not only of the endothelial layer but also of the entire graft, with ensuing rejection. This review focuses on strategies targeted at protecting the endothelium from such damaging effects, ranging from genetic manipulation of the donor organ to soluble, as well as membrane-targeted, protective strategies.
Banz
Yara
Y
Department of Clinical Research, University of Bern, Switzerland.
Rieben
Robert
R
D000818:Animals; D030801:Animals, Genetically Modified; D001777:Blood Coagulation / Q000502:physiology; D003167:Complement Activation; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D000939:Epitopes; D006084:Graft Rejection / Q000276:immunology; D019812:Heparan Sulfate Proteoglycans / Q000276:immunology; D006801:Humans; D014183:Transplantation, Heterologous
D000939:Epitopes; D019812:Heparan Sulfate Proteoglycans